AI chatbots are no longer enough to stand out in mental health. Plenty of companies have been building them for therapy, adding them as part of the virtual services they …
Shionogi’s BARDA contract; Scinai finalizes CDMO unit setup
Plus, news about WuXi XDC: 💰 Shionogi’s BARDA contract for Fetroja: The drugmaker has been awarded a contract worth $119 million, with the potential to increase to $482 million, from the …
Roche dips into DACs with existing partner C4 Therapeutics for $20M upfront
While antibody-drug conjugates have had their moment in the sun for the past few years, a degrader twist on the hot cancer modality is gathering steam. Roche is further delving into its decade-long partnership with …
China-based AI biotech Ailux hires CSO, eyes clinic in 2027
A former AstraZeneca scientist is joining Ailux, a little-known Shanghai-based upstart that has grown into a leading force in China’s AI-focused biotech industry. Ailux has hired Maria Belvisi as its chief scientific officer, Endpoints News …
Pulmonary fibrosis drug developer Avalyn files IPO
Avalyn Pharma hops on the IPO train, filing to list on the Nasdaq and raise funds for late-stage trials of its inhaled pulmonary fibrosis therapies.
Can Anthropic Keep Its Exploit-Writing AI Out of the Wrong Hands?
Its Mythos Preview model, which can allegedly find and exploit critical zero-days, also comes with certain controls, the vendor said.
NHS risks missing out on independent prescriber benefits
Gaps in support could undermine a wave of new independent prescribers entering the NHS and a push for more community-based care, warns a new report.
AbbVie tries a new approach in 340B programme battle
AbbVie has opened a new front in the pharma industry’s efforts to reform the 340B drug discounting programme for safety net hospitals in the US.
23andMe study explains variable results with obesity drugs
Gene variants could explain why some people lose more weight than others with GLP-1 drugs, and why some are more prone to side effects.
RFK Jr. launching health podcast to expose ‘hypocrisy’ and ‘corruption’
Robert F. Kennedy Jr. is starting a podcast. Unveiling the show on social media, the Department of Health and Human Services (HHS) secretary framed the podcast as a response to public health problems that he said have made “many of us … come to the conclusion that [the] government actually lies to us.”
Syneron raises $150m for macrocylics, and other financings
Our round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder.
Syneron raises $150m for macrocyclics, and other financings
Our round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder.